Waters Corporation (WAT) EV/EBIT Ratio: 54.26x
Is Waters Corporation’s EV/EBIT ratio high or low?
Waters Corporation's EV/EBIT ratio of 54.26x is 107% above its 5-year average of 26.24x, near the high end of its 5-year range (18.62x–56.86x).
As of Thursday, June 11, 2026. 96.96% above its 12-month average of 27.55x.
WAT EV/EBIT Ratio Chart
WAT Average EV/EBIT Ratio Chart
WAT Current vs Average EV/EBIT Ratio Chart
WAT EV/EBIT Ratio Metrics
EV/EBIT RATIO
54.26x
EV/EBIT RATIO AVG TTM
27.55x
EV/EBIT RATIO AVG 3Y
26.51x
EV/EBIT RATIO AVG 5Y
26.24x
EV/EBIT RATIO AVG 10Y
25.03x
EV/EBIT RATIO AVG 15Y
22.94x
EV/EBIT RATIO AVG 20Y
21.55x
CURRENT VS TTM AVG
+96.96%
CURRENT VS 3Y AVG
+104.71%
CURRENT VS 5Y AVG
+106.81%
CURRENT VS 10Y AVG
+116.79%
CURRENT VS 15Y AVG
+136.56%
CURRENT VS 20Y AVG
+151.74%
WAT Competitors' EV/EBIT Ratio
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Waters Corporation (WAT) | $23.21B | 54.26x | 27.55x | 26.51x | 26.24x |
| United Therapeutics Corporation (UTHR) | $23.15B | 17.17x | 13.73x | 11.86x | 13.36x |
| Mettler-Toledo International Inc. (MTD) | $22.82B | 21.89x | 26.08x | 26.29x | 29.24x |
| BioNTech SE (BNTX) | $22.39B | N/A | 4.91x | 5.85x | 5.85x |
| Veeva Systems Inc. (VEEV) | $26.31B | 26.56x | 45.54x | 60.66x | 66.33x |
| Moderna, Inc. (MRNA) | $18.71B | N/A | 23.08x | 30.94x | 30.94x |
| DexCom, Inc. (DXCM) | $28.92B | 28.80x | 38.63x | 65.25x | 101.86x |
| Biogen Inc. (BIIB) | $28.94B | 20.85x | 13.29x | 14.80x | 15.73x |
| Hologic, Inc. (HOLX) | $16.97B | 24.28x | 22.66x | 24.05x | 18.32x |
| IQVIA Holdings Inc. (IQV) | $30.08B | 13.37x | 20.38x | 24.02x | 30.00x |
Waters Corporation EV/EBIT Ratio Formula & Definition
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Waters Corporation EV/EBIT Ratio FAQ
- What is the EV/EBIT ratio for Waters Corporation (WAT)?
- The EV/EBIT ratio for WAT stock is 54.26x.
- Is Waters Corporation's EV/EBIT ratio high or low?
- Waters Corporation's EV/EBIT ratio of 54.26x is 107% above its 5-year average of 26.24x, near the high end of its 5-year range (18.62x–56.86x).
- What is the TTM average EV/EBIT ratio for Waters Corporation (WAT)?
- The TTM average EV/EBIT ratio for WAT stock is 27.55x.
- What is the 3Y average EV/EBIT ratio for Waters Corporation (WAT)?
- The 3Y average EV/EBIT ratio for WAT stock is 26.51x.
- What is the 5Y average EV/EBIT ratio for Waters Corporation (WAT)?
- The 5Y average EV/EBIT ratio for WAT stock is 26.24x.
- What is the 10Y average EV/EBIT ratio for Waters Corporation (WAT)?
- The 10Y average EV/EBIT ratio for WAT stock is 25.03x.
- What is the 15Y average EV/EBIT ratio for Waters Corporation (WAT)?
- The 15Y average EV/EBIT ratio for WAT stock is 22.94x.
- What is the 20Y average EV/EBIT ratio for Waters Corporation (WAT)?
- The 20Y average EV/EBIT ratio for WAT stock is 21.55x.
Waters Corporation EV/EBIT Ratio History
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-06-10 | 54.26x |
| 2026-06-09 | 55.28x |
| 2026-06-08 | 54.28x |
| 2026-06-05 | 54.54x |
| 2026-06-04 | 55.96x |
| 2026-06-03 | 56.38x |
| 2026-06-02 | 55.38x |
| 2026-06-01 | 56.17x |
| 2026-05-29 | 56.86x |
| 2026-05-28 | 54.71x |
| 2026-05-27 | 51.58x |
| 2026-05-26 | 51.13x |
| 2026-05-22 | 51.61x |
| 2026-05-21 | 51.43x |
| 2026-05-20 | 51.47x |
| 2026-05-19 | 50.44x |
| 2026-05-18 | 50.31x |
| 2026-05-15 | 49.93x |
| 2026-05-14 | 50.44x |
| 2026-05-13 | 50.66x |
| 2026-05-12 | 52.86x |
| 2026-05-11 | 25.76x |
| 2026-05-08 | 26.26x |
| 2026-05-07 | 25.93x |
| 2026-05-06 | 25.86x |
| 2026-05-05 | 25.37x |
| 2026-05-04 | 22.48x |
| 2026-05-01 | 22.85x |
| 2026-04-30 | 23.00x |
| 2026-04-29 | 21.79x |
| 2026-04-28 | 22.40x |
| 2026-04-27 | 22.33x |
| 2026-04-24 | 23.05x |
| 2026-04-23 | 23.14x |
| 2026-04-22 | 24.79x |
| 2026-04-21 | 24.85x |
| 2026-04-20 | 24.87x |
| 2026-04-17 | 24.32x |
| 2026-04-16 | 23.70x |
| 2026-04-15 | 24.21x |
| 2026-04-14 | 24.55x |
| 2026-04-13 | 24.10x |
| 2026-04-10 | 23.77x |
| 2026-04-09 | 23.60x |
| 2026-04-08 | 23.66x |
| 2026-04-07 | 22.87x |
| 2026-04-06 | 22.64x |
| 2026-04-02 | 22.65x |
| 2026-04-01 | 22.34x |
| 2026-03-31 | 22.19x |
| 2026-03-30 | 21.88x |
| 2026-03-27 | 21.58x |
| 2026-03-26 | 22.39x |
| 2026-03-25 | 22.51x |
| 2026-03-24 | 22.48x |
| 2026-03-23 | 22.48x |
| 2026-03-20 | 22.28x |
| 2026-03-19 | 22.32x |
| 2026-03-18 | 22.00x |
| 2026-03-17 | 22.14x |
| 2026-03-16 | 21.64x |
| 2026-03-13 | 21.40x |
| 2026-03-12 | 21.17x |
| 2026-03-11 | 22.17x |
| 2026-03-10 | 22.32x |
| 2026-03-09 | 22.75x |
| 2026-03-06 | 22.53x |
| 2026-03-05 | 23.45x |
| 2026-03-04 | 23.70x |
| 2026-03-03 | 23.21x |
| 2026-03-02 | 22.86x |
| 2026-02-27 | 23.72x |
| 2026-02-26 | 23.97x |
| 2026-02-25 | 23.73x |
| 2026-02-24 | 24.21x |
| 2026-02-23 | 24.32x |
| 2026-02-20 | 25.35x |
| 2026-02-19 | 25.02x |
| 2026-02-18 | 24.94x |
| 2026-02-17 | 24.49x |
| 2026-02-13 | 24.63x |
| 2026-02-12 | 24.38x |
| 2026-02-11 | 25.06x |
| 2026-02-10 | 24.90x |
| 2026-02-09 | 24.98x |
| 2026-02-06 | 28.82x |
| 2026-02-05 | 28.51x |
| 2026-02-04 | 29.04x |
| 2026-02-03 | 28.65x |
| 2026-02-02 | 28.68x |
| 2026-01-30 | 28.06x |
| 2026-01-29 | 28.38x |
| 2026-01-28 | 29.09x |
| 2026-01-27 | 29.46x |
| 2026-01-26 | 29.52x |
| 2026-01-23 | 29.62x |
| 2026-01-22 | 30.21x |
| 2026-01-21 | 29.94x |
| 2026-01-20 | 29.01x |
| 2026-01-16 | 29.26x |
| 2026-01-15 | 29.79x |
| 2026-01-14 | 29.69x |
| 2026-01-13 | 29.75x |
| 2026-01-12 | 29.72x |
| 2026-01-09 | 29.94x |
| 2026-01-08 | 29.93x |
| 2026-01-07 | 30.13x |
| 2026-01-06 | 30.22x |
| 2026-01-05 | 29.81x |
| 2026-01-02 | 28.87x |
| 2025-12-31 | 28.72x |
| 2025-12-30 | 29.02x |
| 2025-12-29 | 29.10x |
| 2025-12-26 | 29.17x |
| 2025-12-24 | 29.08x |
| 2025-12-23 | 28.96x |
| 2025-12-22 | 29.03x |
| 2025-12-19 | 28.59x |
| 2025-12-18 | 28.46x |
| 2025-12-17 | 28.52x |
| 2025-12-16 | 28.62x |
| 2025-12-15 | 29.12x |
| 2025-12-12 | 29.12x |
| 2025-12-11 | 29.61x |
| 2025-12-10 | 29.87x |
| 2025-12-09 | 29.18x |
| 2025-12-08 | 29.65x |
| 2025-12-05 | 29.80x |
| 2025-12-04 | 29.91x |
| 2025-12-03 | 30.00x |
| 2025-12-02 | 30.08x |
| 2025-12-01 | 30.02x |
| 2025-11-28 | 30.42x |
| 2025-11-26 | 30.69x |
| 2025-11-25 | 31.08x |
| 2025-11-24 | 30.14x |
| 2025-11-21 | 29.74x |
| 2025-11-20 | 28.63x |
| 2025-11-19 | 28.46x |
| 2025-11-18 | 28.49x |
| 2025-11-17 | 28.58x |
| 2025-11-14 | 28.69x |
| 2025-11-13 | 28.68x |
| 2025-11-12 | 29.26x |
| 2025-11-11 | 29.17x |
| 2025-11-10 | 28.48x |
| 2025-11-07 | 28.13x |
| 2025-11-06 | 28.09x |
| 2025-11-05 | 28.15x |
| 2025-11-04 | 27.81x |
| 2025-11-03 | 25.83x |
| 2025-10-31 | 26.12x |
| 2025-10-30 | 25.64x |
| 2025-10-29 | 25.68x |
| 2025-10-28 | 25.86x |
| 2025-10-27 | 26.27x |
| 2025-10-24 | 26.82x |
| 2025-10-23 | 26.55x |
| 2025-10-22 | 26.05x |
| 2025-10-21 | 26.09x |
| 2025-10-20 | 25.66x |
| 2025-10-17 | 25.06x |
| 2025-10-16 | 25.08x |
| 2025-10-15 | 24.90x |
| 2025-10-14 | 24.95x |
| 2025-10-13 | 25.18x |
| 2025-10-10 | 24.80x |
| 2025-10-09 | 24.76x |
| 2025-10-08 | 24.57x |
| 2025-10-07 | 23.91x |
| 2025-10-06 | 24.56x |
| 2025-10-03 | 24.62x |
| 2025-10-02 | 24.16x |
| 2025-10-01 | 24.01x |
| 2025-09-30 | 22.60x |
| 2025-09-29 | 21.86x |
| 2025-09-26 | 22.02x |
| 2025-09-25 | 21.75x |
| 2025-09-24 | 22.09x |
| 2025-09-23 | 22.55x |
| 2025-09-22 | 22.79x |
| 2025-09-19 | 22.67x |
| 2025-09-18 | 23.06x |
| 2025-09-17 | 22.87x |
| 2025-09-16 | 22.83x |
| 2025-09-15 | 22.54x |
| 2025-09-12 | 22.28x |
| 2025-09-11 | 22.78x |
| 2025-09-10 | 22.12x |
| 2025-09-09 | 22.65x |
| 2025-09-08 | 23.27x |
| 2025-09-05 | 23.06x |
| 2025-09-04 | 22.59x |
| 2025-09-03 | 21.91x |
| 2025-09-02 | 22.36x |
| 2025-08-29 | 22.74x |
| 2025-08-28 | 22.44x |
| 2025-08-27 | 22.23x |
| 2025-08-26 | 22.34x |
| 2025-08-25 | 22.54x |
| 2025-08-22 | 22.76x |
| 2025-08-21 | 21.93x |
| 2025-08-20 | 22.38x |
| 2025-08-19 | 22.45x |
| 2025-08-18 | 21.86x |
| 2025-08-15 | 22.01x |
| 2025-08-14 | 22.15x |
| 2025-08-13 | 22.39x |
| 2025-08-12 | 21.59x |
| 2025-08-11 | 21.14x |
| 2025-08-08 | 21.28x |
| 2025-08-07 | 21.05x |
| 2025-08-06 | 21.03x |
| 2025-08-05 | 21.28x |
| 2025-08-04 | 21.59x |
| 2025-08-01 | 21.90x |
| 2025-07-31 | 21.79x |
| 2025-07-30 | 22.52x |
| 2025-07-29 | 22.81x |
| 2025-07-28 | 22.75x |
| 2025-07-25 | 22.79x |
| 2025-07-24 | 22.48x |
| 2025-07-23 | 22.28x |
| 2025-07-22 | 21.70x |
| 2025-07-21 | 21.29x |
| 2025-07-18 | 21.70x |
| 2025-07-17 | 22.37x |
| 2025-07-16 | 21.85x |
| 2025-07-15 | 21.85x |
| 2025-07-14 | 22.88x |
| 2025-07-11 | 26.33x |
| 2025-07-10 | 26.35x |
| 2025-07-09 | 26.06x |
| 2025-07-08 | 25.96x |
| 2025-07-07 | 25.89x |
| 2025-07-03 | 26.14x |
| 2025-07-02 | 26.26x |
| 2025-07-01 | 26.62x |
| 2025-06-30 | 26.05x |
| 2025-06-27 | 26.29x |
| 2025-06-26 | 26.47x |
| 2025-06-25 | 26.12x |
| 2025-06-24 | 25.89x |
| 2025-06-23 | 25.61x |
| 2025-06-20 | 25.60x |
| 2025-06-18 | 25.37x |
| 2025-06-17 | 25.49x |
| 2025-06-16 | 25.97x |
| 2025-06-13 | 25.58x |
| 2025-06-12 | 26.09x |
| 2025-06-11 | 25.84x |
| 2025-06-10 | 26.11x |
| 2025-06-09 | 26.00x |
| 2025-06-06 | 26.20x |
| 2025-06-05 | 25.86x |
| 2025-06-04 | 26.34x |
| 2025-06-03 | 26.08x |
| 2025-06-02 | 25.67x |
| 2025-05-30 | 26.07x |
| 2025-05-29 | 26.50x |
Showing the most recent 260 of 5,031 data points. The chart above shows the full history.
Related Metrics
About Waters Corporation
Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Udit Batra